Elevated serum CRP has been reported to be associated with various unfavorable prognostic factors, such as a larger tumor size, aggressive histopathological type, and high serum levels of interleukin-6, which plays a crucial role in tumor growth and chemoresistance30–32. This evidence concerns the gene CRP and neoplasm.